8-K
Current Report
CRISPR Therapeutics AG Filed Acc 0001564590-19-046006
Material agreement · Agreement ended · Acquisition or sale completed
- Item 1.01 Entry into a material definitive agreement
- Item 1.02 Termination of a material definitive agreement
- Item 2.01 Completion of acquisition or disposition of assets
From the SEC's structured data for this filing
Loading crsp-8k_20191213.htm…